Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma

NCT01392209 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Brain Cancer
MALIGNANT GLIOMA
Glioblastoma
Anaplastic Astrocytoma (AA)
Anaplastic Oligodendroglioma (AO)
Anaplastic Oligo-astrocytoma (AOA)
Anaplastic Mixed Gliomas
Malignant Glioma NOS

Interventions

OTHER: Bevacizumab & Stereotactic Radiotherapy

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]
[object Object]
[object Object]